FOSCHI, CLAUDIO
 Distribuzione geografica
Continente #
EU - Europa 22.511
NA - Nord America 11.553
AS - Asia 10.240
AF - Africa 764
SA - Sud America 754
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 14
Totale 45.874
Nazione #
IT - Italia 14.978
US - Stati Uniti d'America 11.241
SG - Singapore 2.939
CN - Cina 2.510
VN - Vietnam 2.235
GB - Regno Unito 1.758
DE - Germania 1.162
FR - Francia 883
HK - Hong Kong 752
SE - Svezia 705
NL - Olanda 647
UA - Ucraina 551
IN - India 541
BR - Brasile 536
RU - Federazione Russa 409
BD - Bangladesh 313
IE - Irlanda 296
CA - Canada 197
ZA - Sudafrica 193
KR - Corea 186
FI - Finlandia 175
CI - Costa d'Avorio 171
JP - Giappone 158
CH - Svizzera 149
EE - Estonia 115
TG - Togo 97
NG - Nigeria 92
AR - Argentina 90
ID - Indonesia 86
ES - Italia 83
PL - Polonia 79
GR - Grecia 72
PH - Filippine 69
SC - Seychelles 68
AT - Austria 63
BE - Belgio 63
TH - Thailandia 63
BG - Bulgaria 57
TR - Turchia 57
MX - Messico 54
HR - Croazia 44
JO - Giordania 44
IQ - Iraq 41
TW - Taiwan 40
RO - Romania 38
EG - Egitto 37
CL - Cile 33
AU - Australia 32
IR - Iran 32
PK - Pakistan 30
EC - Ecuador 29
UZ - Uzbekistan 26
AL - Albania 23
BB - Barbados 21
MA - Marocco 20
LT - Lituania 19
MY - Malesia 18
SA - Arabia Saudita 18
SK - Slovacchia (Repubblica Slovacca) 18
CO - Colombia 17
CZ - Repubblica Ceca 16
HU - Ungheria 15
KE - Kenya 15
KZ - Kazakistan 15
PY - Paraguay 15
PE - Perù 14
TN - Tunisia 14
DK - Danimarca 13
SM - San Marino 13
DZ - Algeria 12
GH - Ghana 12
LU - Lussemburgo 11
PT - Portogallo 11
NO - Norvegia 10
RS - Serbia 10
IL - Israele 9
LB - Libano 8
AE - Emirati Arabi Uniti 7
EU - Europa 7
VE - Venezuela 7
BA - Bosnia-Erzegovina 6
CM - Camerun 6
CR - Costa Rica 6
HN - Honduras 6
UY - Uruguay 6
XK - ???statistics.table.value.countryCode.XK??? 6
AZ - Azerbaigian 5
BO - Bolivia 5
CY - Cipro 5
DO - Repubblica Dominicana 5
MN - Mongolia 5
SI - Slovenia 5
ET - Etiopia 4
IS - Islanda 4
NZ - Nuova Zelanda 4
OM - Oman 4
PA - Panama 4
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MT - Malta 3
Totale 45.802
Città #
Singapore 2.019
Southend 1.440
Ashburn 1.312
Milan 1.310
Rome 964
Hong Kong 717
Chandler 696
Bologna 695
Fairfield 572
Ann Arbor 570
San Jose 554
Santa Clara 528
Ho Chi Minh City 484
Hanoi 427
Houston 365
Beijing 357
Princeton 342
Hefei 333
Frankfurt am Main 305
Wilmington 294
Boardman 293
Naples 288
Dublin 278
Seattle 267
New York 264
Turin 264
Los Angeles 259
Woodbridge 248
Dong Ket 240
Lauterbourg 214
Dallas 212
Padova 208
Florence 199
Palermo 197
Bari 176
Cambridge 172
Abidjan 171
Nanjing 156
Council Bluffs 153
Catania 151
Westminster 145
Berlin 141
Seoul 134
Buffalo 125
Helsinki 125
Redmond 124
Genoa 111
Tokyo 110
Medford 102
Lomé 97
Verona 94
Jinan 86
Dearborn 83
São Paulo 83
Redondo Beach 81
Brescia 80
Toronto 79
Guangzhou 75
Abeokuta 72
Saint Petersburg 72
Orem 70
Parma 70
Shenyang 70
Modena 69
Da Nang 65
Cagliari 64
San Diego 62
Haiphong 59
San Francisco 58
Shanghai 58
Changsha 56
London 56
Hebei 53
Rimini 53
Napoli 52
Sofia 52
Treviso 52
Chicago 51
Perugia 51
Phoenix 50
Jakarta 45
Pescara 45
Redwood City 45
Brooklyn 44
Nanchang 44
Amman 43
Reggio Emilia 42
Trieste 42
Bergamo 41
Tianjin 41
Bolzano 40
Denver 40
Paris 40
Pisa 40
Venice 40
Montreal 38
Brussels 37
Falls Church 37
Nuremberg 36
Ancona 35
Totale 22.699
Nome #
IMPIEGO DI REAL-TIME PCR PER LA DIAGNOSI DI LABORATORIO DI INFEZIONI DA CHLAMYDIA TRACHOMATIS E NEISSERIA GONORRHOEAE 2.801
Epidemiologia delle infezioni genitali da Mollicutes 1.603
Gardnerella vaginalis in donne con diverse condizioni cliniche 1.494
PERFORMANCE DEL WESTERN BLOT COMPARATIVO NELLA DIAGNOSI DI TOXOPLASMOSI CONGENITA IN NEONATI DA MADRI CON SIEROCONVERSIONE TARDIVA 1.329
LIMITAZIONE DELL’USO DELL’IMMUNOBLOT PER LA CONFERMA DI ANTICORPI ANTI-HCV DOPO INTRODUZIONE DEL TEST VIDAS® ANTI-HCV 1.258
MICOPLASMI UROGENITALI IN NEONATI PREMATURI 969
Mollicutes e microbiota vaginale 886
Caratterizzazione fenotipica e genotipica di ceppi di Staphylococcus aureus isolati in corso di batteriemia 800
Accuratezza della spettrometria di massa MALDI-TOF nell’identificazione di specie di lattobacilli 743
In vitro anti-Candida activity of a Spirulina platensis extract: a new approach for the treatment of fungal infections? 741
Lactobacillus Biofilms Influence Anti-Candida Activity 734
STUDIO IN VITRO DELL’ATTIVITA’ ANTI-FUNGINA DI UN ESTRATTO DI SPIRULINA PLATENSIS: UN NUOVO APPROCCIO PER IL TRATTAMENTO DELLE CANDIDOSI MUCO-CUTANEE? 690
SIFILIDE: UN PROBLEMA ANCORA ATTUALE 533
NUOVI APPROCCI PER L’IDENTIFICAZIONE DI SPECIE DI LATTOBACILLI: RUOLO DELLA SPETTROMETRIA DI MASSA MALDI-TOF E DELLA METABOLOMICA 495
VALUTAZIONE DEL SISTEMA IMMULITE® 2000 PER LO SCREENING SIEROLOGICO DELLE INFEZIONI DA TOXOPLASMA GONDII, CYTOMEGALOVIRUS E ROSOLIA 483
PREVALENZA DI INFEZIONI RETTALI E FARINGEE DA CHLAMYDIA TRACHOMATIS E NEISSERIA GONORRHOEAE IN UNA POPOLAZIONE AD ALTO RISCHIO 478
DIAGNOSI MOLECOLARE DI LINFOGRANULOMA VENEREO SU TAMPONI RETTALI. 466
BIFIDOBACTERIUM BREVE BC104: ORALLY ADMINISTERED VAGINAL PROBIOTIC FOR PREVENTING GENITAL AND URINARY TRACT INFECTIONS 410
SORVEGLIANZA DI TOXOPLASMOSI CONGENITA PRESSO IL POLICLINICO S. ORSOLA-MALPIGHI, BOLOGNA 387
ALTERAZIONI DEL MICROBIOMA FARINGEO IN CORSO DI INFEZIONI DA NEISSERIA GONORRHOEAE 386
VALUTAZIONE DEL VERIGENE GRAM-NEGATIVE BLOOD CULTURE TEST PER L’IDENTIFICAZIONE DI SPECIE E DEI DETERMINANTI DI RESISTENZA AI BETA-LATTAMICI DA FLACONI POSITIVI DI EMOCOLTURA 381
MICROBIOTA VAGINALE IN CORSO DI INFEZIONI DEL TRATTO GENITALE 354
TOXOPLASMOSI ACUTA IN PAZIENTE IMMUNOCOMPETENTE: QUAL’E’ IL RUOLO DEGLI ESAMI DI BIOLOGIA MOLECOLARE? 334
Studio del profilo metabolico di ceppi di Klebsiella pneumoniae mediante spettroscopia di risonanza magnetica nucleare (1H-NMR) 316
Antifungal Activity of Natural Compounds vs. Candida spp.: A Mixture of Cinnamaldehyde and Eugenol Shows Promising In Vitro Results 311
Isolation of vaginal lactobacilli and characterization of anti-candida activity 303
Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study 300
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells. 289
Metaboloma urinario in donne con infezione da Chlamydia trachomatis 286
Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis 283
RILEVAZIONE DELLA STRUTTURA MOSAICO DEL GENE PENA IN SEDE ORO-FARINGEA 281
VALUTAZIONE DELLE PERFORMANCE ANALITICHE DI IMMULITE® 2000 E BIOPLEX® 2200 PER LO SCREENING SIEROLOGICO DELLE INFEZIONI DA TOXOPLASMA GONDII, CYTOMEGALOVIRUS E VIRUS DELLA ROSOLIA 274
Pharyngeal Chlamydia and gonorrhea: a hidden problem 274
Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice 272
In vitro activity of Spirulina platensis water extract against different Candida species isolated from vulvo-vaginal candidiasis cases. 259
Impact of meropenem on Klebsiella pneumoniae metabolism 252
Pre-Pregnancy Diet and Vaginal Environment in Caucasian Pregnant Women: An Exploratory Study 242
Mosaic structure of the penA gene in the oropharynx of men who have sex with men negative for gonorrhoea 238
Urine metabolome in women with Chlamydia trachomatis infection 229
Sexually transmitted rectal infections in a cohort of 'men having sex with men' 229
Survival and death of intestinal cells infected by Chlamydia trachomatis 229
Diversity of vaginal microbiome and metabolome during genital infections 227
Lactobacilli extracellular vesicles: potential postbiotics to support the vaginal microbiota homeostasis 223
Epidemiologia delle infezione faringee da Chlamydia trachomatis e Neisseria gonorrhoeae 223
Distribution of genital Mollicutes in the vaginal ecosystem of women with different clinical conditions 221
Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains 218
UTILIZZO DI SL SOLUTION, COPAN, PER LA DIAGNOSI MOLECOLARE DI INFEZIONI RESPIRATORIE DA CHLAMYDIA PNEUMONIAE E MYCOPLASMA PNEUMONIAE 214
A Deep Look at the Vaginal Environment During Pregnancy and Puerperium 213
Low-dose doxycycline induces Chlamydia trachomatis persistence in HeLa cells 213
Activity of cathelicidin peptides against Simkania negevensis 211
DETERMINAZIONE DELLA PRODUZIONE DI CARBAPENEMASI IN ENTEROBATTERI CON RIDOTTA SENSIBILITA’ AI CARBAPENEMI MEDIANTE METODICA LC-MS (LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY) 207
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 205
Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 202
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 199
Pharyngeal microbiome alterations during Neisseria gonorrhoeae infection 199
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 199
Distribution of ermB, ermF, tet(W), and tet(M) resistance genes in the vaginal ecosystem of women during pregnancy and puerperium 195
A year in a sexually-transmitted disease (STD) outpatients clinic in Italy: prevalence and characteristics of chlamydia, gonorrhoea and syphilis infections 194
Vaginal metabolic profiles during pregnancy: Changes between first and second trimester 193
Dual-color bioluminescent assay using infected HepG2 cells sheds new light on Chlamydia pneumoniae and human cytomegalovirus effects on human cholesterol 7α-hydroxylase (CYP7A1) transcription. 191
A Case of Reactive Arthritis Associated With Lymphogranuloma Venereum Infection in a Woman 191
Evaluation of cytokines and matrix metalloproteinases genes expression in genital organs after vaginal exposure to Chlamydia muridarum 190
Pharyngeal chlamydia and gonorrhoea: a hidden problem. 190
Anti-chlamydial activity of vaginal fluids: new evidence from an in vitro model 189
First-Void Urine Microbiome in Women with Chlamydia trachomatis Infection 188
Vaginal Lactobacillus strains interfere with Chlamydia trachomatis infection 188
Whole Genome Sequencing of a Chlamydia trachomatis Strain Responsible for a Case of Rectal Lymphogranuloma Venereum in Italy 183
Studio in vitro dell’attività antimicrobica di lattobacilli vaginali nei confronti di Chlamydia trachomatis. 183
In-vitro effect of vaginal lactobacilli against group B Streptococcus 182
Dietary habits and vaginal environment: can a beneficial impact be expected? 179
Rescue of Chlamydia trachomatis tryptophan depletion with indole 178
Cap. 4- IL MICROBIOMA OCULARE E IMPATTO SUL SISTEMA IMMUNE 177
Evaluation of the Versant CT/GC DNA 1.0 Assay (kPCR) for the Detection of Extra-Genital Chlamydia trachomatis and Neisseria gonorrhoeae Infections. 175
Rectal Microbiota Associated With Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Men Having Sex With Other Men 175
UN CASO DI FEBBRE REUMATICA ACUTA: CARATTERISTICHE CLINICHE E MICROBIOLOGICHE 174
Contribution of a comparative western blot method to early postnatal diagnosis of congenital syphilis 174
Limosilactobacillus vaginalis Exerts Bifidogenic Effects: A Novel Postbiotic Strategy for Infant Prebiotic Supplementation 173
Valutazione del test Aptima Combo 2 per la diagnosi molecolare di infezioni da Chlamydia trachomatis e Neisseria gonorrhoeae 172
Approcci innovativi per l’identificazione di specie di lattobacilli: studio dei metaboliti mediante spettrometria di risonanza magnetica (1H-RMN) 171
Prevalence and antimicrobial resistance of genital Mollicutes in Italy over a two-year period 171
New Insights into Vaginal Environment During Pregnancy 171
Gardnerella vaginalis clades in pregnancy: New insights into the interactions with the vaginal microbiome 170
Chlamydia trachomatis serovar distribution and other sexually transmitted coinfections in subjects attending a STD Outpatients Clinic in Italy. 168
Metabolic profiling of Candida clinical isolates of different species and infection sources 168
Chlamydial conjunctivitis in newborns: Case report and screening opportunities 167
Insights into penicillin-induced Chlamydia trachomatis persistence 167
Non-pathogenic Neisseria species of the oropharynx as a reservoir of antimicrobial resistance: a cross-sectional study 164
Evaluation of the Aptima assays for the detection of bacterial sexually transmitted infections in a selected population of women 164
Vaginal Lactobacilli Reduce Neisseria gonorrhoeae Viability through Multiple Strategies: An in Vitro Study. 163
Vaginal metabolites in postmenopausal women with or without vulvo-vaginal atrophy at baseline and after ospemifeme and systemic hormone treatment 163
Role of D(-)-Lactic Acid in Prevention of Chlamydia trachomatis Infection in an In Vitro Model of HeLa Cells 162
Chlamydia trachomatis Serovar Distribution and Other Sexually Transmitted Coinfections in Subjects Attending a STD Outpatients Clinic in Italy 162
Valutazione del sistema BD ProbeTec CT/GC Qx DNA Amplified assay su piattaforma BD Viper LT per la diagnosi molecolare di infezioni da Chlamydia trachomatis e Neisseria gonorrhoeae 160
Chlamydia trachomatis infection prevalence and serovar distribution in a high-density urban area in the North of Italy 159
Metabolic fingerprints of different clinical conditions affecting women’s genital tract 158
Vaginal and anal microbiome during chlamydia trachomatis infections 158
Meningococcal Carriage in ‘Men Having Sex With Men’ With Pharyngeal Gonorrhoea 158
Lactobacillus crispatus interferes with Chlamydia trachomatis infectivity through modulation of integrin exposure in cervical cells 157
Lactobacillus crispatus BC1 Biosurfactant Delivered by Hyalurosomes: An Advanced Strategy to Counteract Candida Biofilm 156
Carbapenemase-producing Enterobacterales: changing epidemiology in a highly endemic Italian area 156
Totale 34.423
Categoria #
all - tutte 102.475
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.475


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021924 0 0 0 0 0 0 0 0 0 0 0 924
2021/20224.277 397 253 229 307 409 272 223 302 230 255 724 676
2022/20235.482 507 543 339 617 390 385 327 359 794 353 491 377
2023/20244.865 290 362 437 483 478 494 456 329 281 437 430 388
2024/20258.108 639 948 726 604 1.040 572 616 591 472 496 423 981
2025/202614.051 942 1.066 1.079 1.047 1.339 753 1.419 643 2.303 1.134 1.541 785
Totale 46.630